| 1 |
Zhao N, Cao J, Xu J, et al. Targeting RNA with Next- and third-generation sequencing improves pathogen identification in clinical samples [J]. Adv Sci (Weinh), 2021, 8(23): e2102593.
|
| 2 |
袁莹, 杨颖.. 多粘菌素B和E:如何选择 [J]. 中国感染控制杂志, 2017, 16(7): 677-682.
|
| 3 |
Chebib F T, Torres V E. Autosomal dominant polycystic kidney disease: Core curriculum 2016 [J]. Am J Kidney Dis, 2016, 67(5): 792-810.
|
| 4 |
Chapman A B, Guay-Woodford L M, Grantham J J, et al. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The consortium for radiologic imaging studies of polycystic kidney disease (CRISP) cohort [J]. Kidney Int, 2003, 64(3): 1035-1045.
|
| 5 |
Ong A C, Devuyst O, Knebelmann B, et al. Autosomal dominant polycystic kidney disease: the changing face of clinical management [J]. Lancet, 2015, 385(9981): 1993-2002.
|
| 6 |
Sallée M, Rafat C, Zahar J R, et al. Cyst infections in patients with autosomal dominant polycystic kidney disease [J]. Clin J Am Soc Nephrol, 2009, 4(7): 1183-1189.
|
| 7 |
Rizk D, Chapman A B. Cystic and inherited kidney diseases [J]. Am J Kidney Dis, 2003, 42(6): 1305-1317.
|
| 8 |
Bleeker-Rovers C P, de Sevaux R G, van Hamersvelt H W, et al. Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease [J]. Am J Kidney Dis, 2003, 41(6): E18-E21.
|
| 9 |
Migali G, Annet L, Lonneux M, et al. Renal cyst infection in autosomal dominant polycystic kidney disease [J]. Nephrol Dial Transplant, 2008, 23(1): 404-405.
|
| 10 |
Myint K S, Merchant R A. Is this just another urinary tract infection? [J]. J Am Geriatr Soc, 2015, 63(4): 823-824.
|
| 11 |
Ubee S S, Mcglynn L, Fordham M. Emphysematous pyelonephritis [J]. BJU Int, 2011, 107(9): 1474-1478.
|
| 12 |
孙艳, 多丽波. 耐碳青霉烯类肠杆菌科细菌耐药机制及实验室检测研究进展 [J]. 国际检验医学杂志, 2020, 41(16): 2011-2016.
|
| 13 |
杨雪, 刘琳, 张湘燕. 耐碳青霉烯类肺炎克雷伯杆菌的耐药机制及治疗策略研究进展 [J]. 医学研究生学报, 2018, 31(4): 430-434.
|
| 14 |
Suwabe T, Araoka H, Ubara Y, et al. Cyst infection in autosomal dominant polycystic kidney disease: causative microorganisms and susceptibility to lipid-soluble antibiotics [J]. Eur J Clin Microbiol Infect Dis, 2015, 34(7): 1369-1379.
|
| 15 |
Hiyama L, Tang A, Miller L G. Levofloxacin penetration into a renal cyst in a patient with autosomal dominant polycystic kidney disease [J]. Am J Kidney Dis, 2006, 47(1): e9-e13.
|
| 16 |
龙晓琴, 方丽. 耐碳青霉烯类肺炎克雷伯杆菌感染的研究进展 [J]. 疑难病杂志, 2021, 20(12): 1282-1286.
|
| 17 |
Mazuski J E, Gasink L B, Armstrong J, et al. Efficacy and safety of ceftazidime-avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infection: results from a randomized, controlled, double-blind, phase 3 program [J]. Clin Infect Dis, 2016, 62(11): 1380-1389.
|
| 18 |
王琴, 邹自英, 谭积善, 等. 头孢他啶-阿维巴坦在耐碳青霉烯类肺炎克雷伯菌中的药物敏感性分析 [J]. 检验医学与临床, 2019, 16(6): 802-804.
|
| 19 |
Zhang J, Yu L, Fu Y, et al. Tigecycline in combination with other antibiotics against clinical isolates of carbapenem-resistant Klebsiella pneumoniae in vitro [J]. Ann Palliat Med, 2019, 8(5): 622-631.
|
| 20 |
Wang J, Pan Y, Shen J, et al. The efficacy and safety of tigecycline for the treatment of bloodstream infections: a systematic review and meta-analysis [J]. Ann Clin Microbiol Antimicrob, 2017, 16(1): 24.
|
| 21 |
Lantinga M A, Casteleijn N F, Geudens A, et al. Management of renal cyst infection in patients with autosomal dominant polycystic kidney disease: A systematic review [J]. Nephrology Dialysis Transplantation, 2016: v452.
|
| 22 |
Suwabe T. Cyst infection in autosomal dominant polycystic kidney disease: our experience at Toranomon Hospital and future issues [J]. Clin Exp Nephrol, 2020, 24(9): 748-761.
|